PMID- 21614558 OWN - NLM STAT- MEDLINE DCOM- 20121001 LR - 20211020 IS - 1438-2199 (Electronic) IS - 0939-4451 (Print) IS - 0939-4451 (Linking) VI - 42 IP - 5 DP - 2012 May TI - Cellular hypomethylation is associated with impaired nitric oxide production by cultured human endothelial cells. PG - 1903-11 LID - 10.1007/s00726-011-0916-0 [doi] AB - Hyperhomocysteinemia (HHcy) is a risk factor for vascular disease, but the underlying mechanisms remain incompletely defined. Reduced bioavailability of nitric oxide (NO) is a principal manifestation of underlying endothelial dysfunction, which is an initial event in vascular disease. Inhibition of cellular methylation reactions by S-adenosylhomocysteine (AdoHcy), which accumulates during HHcy, has been suggested to contribute to vascular dysfunction. However, thus far, the effect of intracellular AdoHcy accumulation on NO bioavailability has not yet been fully substantiated by experimental evidence. The present study was carried out to evaluate whether disturbances in cellular methylation status affect NO production by cultured human endothelial cells. Here, we show that a hypomethylating environment, induced by the accumulation of AdoHcy, impairs NO production. Consistent with this finding, we observed decreased eNOS expression and activity, but, by contrast, enhanced NOS3 transcription. Taken together, our data support the existence of regulatory post-transcriptional mechanisms modulated by cellular methylation potential leading to impaired NO production by cultured human endothelial cells. As such, our conclusions may have implications for the HHcy-mediated reductions in NO bioavailability and endothelial dysfunction. FAU - Barroso, M AU - Barroso M AD - Research Institute for Medicines and Pharmaceutical Sciences (iMed.UL), Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal. FAU - Rocha, M S AU - Rocha MS FAU - Esse, R AU - Esse R FAU - Goncalves, I Jr AU - Goncalves I Jr FAU - Gomes, A Q AU - Gomes AQ FAU - Teerlink, T AU - Teerlink T FAU - Jakobs, C AU - Jakobs C FAU - Blom, H J AU - Blom HJ FAU - Loscalzo, J AU - Loscalzo J FAU - Rivera, I AU - Rivera I FAU - de Almeida, I Tavares AU - de Almeida IT FAU - Castro, R AU - Castro R LA - eng GR - U54 HL070819/HL/NHLBI NIH HHS/United States GR - P01 HL048743/HL/NHLBI NIH HHS/United States GR - R01 HL061795/HL/NHLBI NIH HHS/United States GR - HL48743/HL/NHLBI NIH HHS/United States GR - R37 HL061795/HL/NHLBI NIH HHS/United States GR - HL81587/HL/NHLBI NIH HHS/United States GR - P01 HL081587/HL/NHLBI NIH HHS/United States GR - HL70819/HL/NHLBI NIH HHS/United States GR - HL61795/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20110526 PL - Austria TA - Amino Acids JT - Amino acids JID - 9200312 RN - 31C4KY9ESH (Nitric Oxide) RN - 63CV1GEK3Y (N,N-dimethylarginine) RN - 94ZLA3W45F (Arginine) RN - 979-92-0 (S-Adenosylhomocysteine) RN - EC 1.14.13.39 (NOS3 protein, human) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type III) SB - IM MH - Arginine/*analogs & derivatives/metabolism MH - Cells, Cultured MH - Endothelial Cells/*metabolism MH - Gene Expression Regulation MH - Human Umbilical Vein Endothelial Cells MH - Humans MH - Hyperhomocysteinemia/metabolism MH - *Methylation MH - Nitric Oxide/deficiency/*metabolism MH - Nitric Oxide Synthase Type III/antagonists & inhibitors/metabolism MH - S-Adenosylhomocysteine/*metabolism MH - Vascular Diseases/metabolism PMC - PMC3602903 MID - NIHMS449692 EDAT- 2011/05/27 06:00 MHDA- 2012/10/02 06:00 PMCR- 2013/03/20 CRDT- 2011/05/27 06:00 PHST- 2010/11/08 00:00 [received] PHST- 2011/04/08 00:00 [accepted] PHST- 2011/05/27 06:00 [entrez] PHST- 2011/05/27 06:00 [pubmed] PHST- 2012/10/02 06:00 [medline] PHST- 2013/03/20 00:00 [pmc-release] AID - 10.1007/s00726-011-0916-0 [doi] PST - ppublish SO - Amino Acids. 2012 May;42(5):1903-11. doi: 10.1007/s00726-011-0916-0. Epub 2011 May 26.